Does famotidine induce thrombocytopenia in neurosurgical patients?

Journal of Neurosurgical Anesthesiology

Volumn 16, Issue 4, 2004, Pages 291-293

  Ecker, Robert D ^a   Wijdicks, Eelco F M ^a   Wix, Kelly ^a   McClelland, Robyn ^a  

^a Mayo Clinic   (United States)

Author keywords

H2 antagonists; Pepcid; Thrombocytopenia

Indexed keywords

FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR; SUCRALFATE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG PREFERENCE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEUROSURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOPENIC PURPURA; TREATMENT CONTRAINDICATION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; FAMOTIDINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; PLATELET COUNT; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 5044223427     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008506-200410000-00006     Document Type: Article

References (17)

1. Muller P, Jirsch D, D'Sousa J, et al. Gastrointestinal bleeding after craniotomy: a retrospective review of 518 patients. Can J Neurol Sci. 1988;15:384-387.
2. Glavin GB, Murison R, Overmier JB, et al. The neurobiology of stress ulcers. Brain Res Brain Res Rev. 1991;16:301-343.
3. Heiskanen O, Torma T. Gastrointestinal ulceration and hemorrhage associated with severe brain injury. Acta Chir Scand. 1968;134:562-566.
4. Wade EE, Rebuck JA, Healey MA, et al. H(2) antagonist-induced thrombocytopenia: is this a real phenomenon? Intensive Care Med. 2002;28:459-465.
5. Oymak O, Akpolat T, Arik N, et al. Reversible neutropenia and thrombocytopenia during famotidine treatment. Ann Pharmacother. 1994;28:406-407.
6. Sax MJ. Clinically important adverse effects and drug interactions with H2- receptor antagonists: an update. Pharmacotherapy. 1987;7(suppl):110-115.
7. Comer JB, Evans JA, Kerns A. Possible famotidine-induced thrombocytopenia. DICP. 1989;23:507-508.
8. Gafter U, Zevin D, Komlos L, et al. Thrombocytopenia associated with hypersensitivity to ranitidine: possible cross-reactivity with cimetidine. Am J Gastroenterol. 1989;84:560-562.
9. Bajjoka AE. Ranitidine-induced thrombocytopenia. Arch Intern Med. 1991;151:203.
10. Zimmermann AE, Katona BG, Hrehorovich VR. Probable famotidine-induced thrombocytopenia. DICP. 1991;25:678.
11. Humphries JE. Thrombocytopenia associated with famotidine in a hemophiliac. Ann Pharmacother. 1992;26:262.
12. Kallal SM, Lee M. Thrombotic thrombo-cytopenic purpura associated with histamine H2-receptor antagonist therapy. West J Med. 1996; 164:446-448.
13. Gentilini G, Curtis BR, Aster RH. An antibody from a patient with ranitidine-induced thrombocytopenia recognizes a site on glycoprotein IX that is a favored target for drug- induced antibodies. Blood. 1998;92:2359-2365.
14. George JN, Raskob GE, Shah SR, et al. Drug-induced thrombocytopenia: a systematic review of published case reports. Ann Intern Med. 1998; 129:886-890.
15. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost. 1998;79:1-7.
16. Lauritsen K, Rune SJ, Bytzer P, et al. Effect of omeprazole and cimetidine on duodenal ulcer: a double-blind comparative trial. N Engl J Med. 1985;312:958-961.
17. Yeomans ND, Tulassay Z, Juhasz L, et al. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med. 1998;338:719-726.